This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yoon, J.-H. Articles by Gores, G. J. Search for Related Content PubMed PubMed Citation Articles by Yoon, J.-H. Articles by Gores, G. J.

Bile Acids Inhibit Mcl-1 Protein Turnover via an Epidermal Growth Factor Receptor/Raf-1-dependent Mechanism¹

Division of Gastroenterology and Hepatology [J-H. Y., N. W. W., H. H., A. E. C., G. J. G.] and Oncology Research [S. H. K.], Mayo Medical School, Clinic, and Foundation, Rochester, Minnesota 55905, and School of Biological Sciences, Life Sciences Building, University of Liverpool, Liverpool L69 7ZB, United Kingdom [C. A., S. W. E.]

Bile acids have been implicated in biliary tract carcinogenesis, in part, by activating the epidermal growth factor receptor (EGFR). Overexpression of Mcl-1, a potent antiapoptotic protein of the Bcl-2 family, has also been reported in cholangiocarcinomas. Because receptor tyrosine kinases like EGFR may modulate antiapoptotic protein expression, we examined the hypothesis that bile acids modulate Mcl-1 expression levels via EGFR. Deoxycholate increased cellular Mcl-1 protein in a concentration-dependent manner. The deoxycholate-mediated increase of cellular Mcl-1 protein was blocked equally by EGFR tyrosine kinase inhibitors or an EGFR-neutralizing antibody. Although inhibition of mitogen-activated protein kinases did not attenuate the deoxycholate-associated increase in Mcl-1 protein, the Raf-1 inhibitor, BAY 37-9751, effectively blocked the cellular increase of this protein. Neither Mcl-1 transcriptional activity nor its mRNA stability was altered by deoxycholate treatment. However, Mcl-1 protein stability was increased by bile acid treatment, an effect duplicated by proteasome inhibition. Deoxycholate prolongation of Mcl-1 turnover was blocked by either EGFR inhibitors or the Raf-1 inhibitor. Whereas the deoxycholate-induced increase in Mcl-1 reduced Fas-mediated apoptosis, the Raf-1 inhibitor potentiated Fas apoptosis. Our results demonstrate that bile acids block Mcl-1 protein degradation via activation of an EGFR/Raf-1 cascade resulting in its cellular accumulation. Raf-1 inhibitors block this increase of Mcl-1 and render the cells more susceptible to apoptosis, a potential therapeutic strategy for cholangiocarcinomas.

This article has been cited by other articles:

				S. M. Wilhelm, L. Adnane, P. Newell, A. Villanueva, J. M. Llovet, and M. Lynch Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling Mol. Cancer Ther., October 1, 2008; 7(10): 3129 - 3140. [Abstract] [Full Text] [PDF]

				A. Cross, R. J. Moots, and S. W. Edwards The dual effects of TNF{alpha} on neutrophil apoptosis are mediated via differential effects on expression of Mcl-1 and Bfl-1 Blood, January 15, 2008; 111(2): 878 - 884. [Abstract] [Full Text] [PDF]

				A. Cross, T. Barnes, R. C. Bucknall, S. W. Edwards, and R. J. Moots Neutrophil apoptosis in rheumatoid arthritis is regulated by local oxygen tensions within joints J. Leukoc. Biol., September 1, 2006; 80(3): 521 - 528. [Abstract] [Full Text] [PDF]

				C. Han, A. J. Demetris, D. B. Stolz, L. Xu, K. Lim, and T. Wu Modulation of Stat3 Activation by the Cytosolic Phospholipase A2{alpha} and Cyclooxygenase-2-controlled Prostaglandin E2 Signaling Pathway J. Biol. Chem., August 25, 2006; 281(34): 24831 - 24846. [Abstract] [Full Text] [PDF]

				F. Leone, G. Cavalloni, Y. Pignochino, I. Sarotto, R. Ferraris, W. Piacibello, T. Venesio, L. Capussotti, M. Risio, and M. Aglietta Somatic mutations of epidermal growth factor receptor in bile duct and gallbladder carcinoma. Clin. Cancer Res., March 15, 2006; 12(6): 1680 - 1685. [Abstract] [Full Text] [PDF]

				M. Derouet, L. Thomas, D. A. Moulding, C. Akgul, A. Cross, R. J. Moots, and S. W. Edwards Sodium Salicylate Promotes Neutrophil Apoptosis by Stimulating Caspase-Dependent Turnover of Mcl-1 J. Immunol., January 15, 2006; 176(2): 957 - 965. [Abstract] [Full Text] [PDF]

				M. Derouet, L. Thomas, A. Cross, R. J. Moots, and S. W. Edwards Granulocyte Macrophage Colony-stimulating Factor Signaling and Proteasome Inhibition Delay Neutrophil Apoptosis by Increasing the Stability of Mcl-1 J. Biol. Chem., June 25, 2004; 279(26): 26915 - 26921. [Abstract] [Full Text] [PDF]

				M. Taniai, A. Grambihler, H. Higuchi, N. Werneburg, S. F. Bronk, D. J. Farrugia, S. H. Kaufmann, and G. J. Gores Mcl-1 Mediates Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Resistance in Human Cholangiocarcinoma Cells Cancer Res., May 15, 2004; 64(10): 3517 - 3524. [Abstract] [Full Text] [PDF]

				N. W. Werneburg, J.-H. Yoon, H. Higuchi, and G. J. Gores Bile acids activate EGF receptor via a TGF-{alpha}-dependent mechanism in human cholangiocyte cell lines Am J Physiol Gastrointest Liver Physiol, June 9, 2003; 285(1): G31 - G36. [Abstract] [Full Text] [PDF]